Filter by:

Reset Filters
    Showing 1525 - 1536 of 1569
    Exclusionary Practices in Managed Care Organizations’ Contracts
    Case

    Exclusionary Practices in Managed Care Organizations’ Contracts

    Cornerstone Research worked with the defense experts in a series of antitrust cases against the manufacturer of a branded drug with a dominant market share in its therapeutic class.

    Express Scripts, Inc., PBM Litigation
    Case

    Express Scripts, Inc., PBM Litigation

    In a proposed class action against pharmacy benefit manager (PBM) Express Scripts, Inc., the named plaintiffs sought to represent five proposed classes of self-funded ERISA plans.

    Failure to Disclose Clinical Trial Results
    Case

    Failure to Disclose Clinical Trial Results

    Counsel for a pharmaceutical company retained Cornerstone Research to assess damages in a securities class action alleging the company misled investors about a drug’s approval probability.

    High-Technology Medical Devices
    Case

    High-Technology Medical Devices

    A leading manufacturer of high-technology medical devices retained Dr. Matthew Lynde, a vice president of Cornerstone Research, to evaluate the patent infringement damages claims of the plaintiff, another manufacturer of…

    Hilton v. Children’s Hospital San Diego
    Case

    Hilton v. Children’s Hospital San Diego

    Counsel for the defendants retained Dr. Michael Keeley, a senior vice president of Cornerstone Research, to evaluate the plaintiff’s antitrust claims from an economic perspective and to assess the validity…

    Irreparable Harm
    Case

    Irreparable Harm

    Cornerstone Research has worked with Professor Henry Grabowski of Duke University on a number of cases to evaluate whether the incumbent branded drug company would suffer irreparable harm if the…

    Misleading Disclosure of Clinical Trial Results
    Case

    Misleading Disclosure of Clinical Trial Results

    Plaintiffs filed a securities class action against a major pharmaceutical company alleging that the company made false and misleading statements regarding the results of a drug’s safety study.

    Pharmaceutical Product Misrepresentation Class Action
    Case

    Pharmaceutical Product Misrepresentation Class Action

    In a class action against a large pharmaceutical company, the plaintiffs alleged that the pharmaceutical company provided false and misleading information about the efficacy and safety of its products, resulting…

    SEC v. Biopure Corporation
    Case

    SEC v. Biopure Corporation

    In litigation brought by the Securities and Exchange Commission (SEC) against Biopure Corporation (Biopure) and several current and former officers of the company involving its drug Hemopure, counsel for Biopure…

    State Fund Provider-Payor Disputes
    Case

    State Fund Provider-Payor Disputes

    State Compensation Insurance Fund (State Fund), a nonprofit enterprise that provides workers’ compensation insurance to California employers, faces claims by multiple ambulatory surgical centers.

    Vision Improvement Products Advertising
    Case

    Vision Improvement Products Advertising

    In a false advertising case, the defendant retained a Cornerstone Research expert to provide testimony on damages.

    In re Ovcon Antitrust Litigation
    Case

    In re Ovcon Antitrust Litigation

    Counsel for codefendant Warner Chilcott retained Cornerstone Research and Professor Henry Grabowski of Duke University to determine if an exclusive supply agreement between Warner Chilcott and Barr Pharmaceuticals had any…

    How can we help you?

    If you are looking for a publication not on our website, contact us.